Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs

Quest Diagnostics Incorporated (DGX) entered into a research collaboration with Broad Clinical Labs — the expert in whole genome sequencing (WGS). The collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.For investors’ note, Broad Clinical Labs is a pioneer in human whole genome sequencing, having sequenced more than 600,000 genomes as part of its aim to expedite the knowledge and diagnosis of human disease.M ...